Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer
Open Access
- 26 February 2002
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 86 (5) , 669-673
- https://doi.org/10.1038/sj.bjc.6600166
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.2000
- The changing epidemiology of esophageal cancer.1999
- Chemotherapy in esophageal cancer.1999
- Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the EsophagusThe American Journal of Pathology, 1999
- Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal AdenocarcinomaNew England Journal of Medicine, 1999
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerNew England Journal of Medicine, 1998
- Neurotoxicity is not enhanced by increased dose intensities of cisplatin administrationEuropean Journal Of Cancer, 1995
- A 15-Year Review of Esophagectomy for Carcinoma of the Esophagus and CardiaArchives of Surgery, 1995
- Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the EsophagusJNCI Journal of the National Cancer Institute, 1994
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992